Features | Partner Sites | Information | LinkXpress
Sign In
BioConferenceLive
JIB
GLOBETECH PUBLISHING

Clinical Trial Research Software Provides Range of Trial Capabilities in Unified Platform

By BiotechDaily International staff writers
Posted on 05 Aug 2013
New clinical trial software provides end-to-end study support through a single, easy-to-use interface that allows the ability to manage and run studies more effectively. It offers built-in study templates, libraries, and reports to help users create studies rapidly and manage them effectively without technical help.

Merge Healthcare. Inc. (Chicago, IL, USA), a provider of clinical systems, reported that SGS Life Science Services (Geneva, Switzerland) , a contract service organization with over 35 years’ experience in clinical research, has selected Merge’s eClinical OS to streamline data management across phase I-IV studies.

“SGS sought a comprehensive EDC solution that would still be cost-effective for our biotech and smaller pharmaceutical clients,” explained Joris De Bondt, head of EDC and data standards of clinical research at SGS Life Science Services. “More specifically, we needed a system that included interactive response and drug dispensing in addition to data capture functionality. We were pleased to find that Merge’s eClinical OS includes such a broad set of capabilities. Using one system for everything needed maximizes efficiency and improves timelines across all our studies.”

“As one of the premier global CROs in the industry, we’re very pleased to have SGS as a partner,” said Zaher El-Assi, general manager of Merge eClinical. “We find that our CRO partners benefit greatly from training and ongoing support through the Merge Certified Designer program. Our goal is to empower our CRO partners to better serve their customers by developing internal expertise to quickly build, test, and deploy trials for their organization regardless of trial complexity and size.”

“We were most impressed with the ability to tailor the system for each study depending on the features needed. The unique pay-as-you go model provides us with more cost efficiencies that we are then able to pass along to our clients,” explained Mr. De Bondt. “Another benefit was how straight-forward the system was to use. Our team was able to learn the system, build a complete trial and have the trial validated and pass user acceptance testing faster than with previous systems.”

Merge eClinical OS provides end-to-end study support through a single, easy-to-use interface allowing clients to manage and run studies more efficiently than ever before. The system works for the largest and smallest studies, has the flexibility to support trials in any phase, and captures any type of data, from any source, from any modality at any time.

Merge also provides clinical trials software, health stations, and other health data and analytics solutions that engage consumers in their personal health.

SGS Life Science Services is a contract service organization (CSO) providing clinical research, biologics characterization, biosafety, and quality control (QC) testing. SGS provides pharmaceutical companies with phase I-IV clinical trial management services encompassing clinical project management and monitoring, pharmacokinetic/pharmacodynamic (PK/PD) simulation and modeling services, data management, biostatistics, and regulatory consultancy.


Related Links:
Merge Healthcare
SGS Life Science Services


comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Microcomputed tomography images (top) and histology images (bottom) of the knees of mice fed a very high fat diet containing omega-3 fatty acid supplement (left) or only omega-6 fatty acids (right) after a knee injury. The omega-6 diet showed abnormal bone remodeling and calcified tissue formation in the joint (white arrow). The omega-6 diet also showed significant loss of cartilage (red staining, yellow arrowhead) and increased joint inflammation (Photo courtesy of Duke University).

Dietary Omega-3 Fatty Acids Moderate Severity of Osteoarthritis in a Mouse Model

Researchers working with an osteoarthritis (OA) obese mouse model found that the fat content of the animals' diet contributed more to the development or arrest of OA than did body weight.... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel

Vaccine Being Developed for Heart Disease Close to Reality

The world’s first vaccine for heart disease is becoming a possibility with researchers demonstrating significant arterial plaque reduction in concept testing in mice. Klaus Ley, MD, from the La Jolla Institute for Allergy and Immunology (LA Jolla, CA, USA), and a vascular immunology specialist, is leading the vaccine... Read more

Business

view channel

A Surge in IPOs Revitalize Investments for the Global Pharma and Biotech

Anti-infective drugs, oncology, and pharmaceutical contract laboratories attract the most investment up to now. The intensified private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008–2010, witnessed a waning post-2010. However, the decline in deals... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.